# FDA Inspection 1065808 - Astrea Fontaine - November 10, 2017

Source: https://www.keypedia.com/records/fda_inspections/astrea-fontaine/1bbf17bb-20d2-4282-9005-60390589e8a5
Source feed: FDA_Inspections

> FDA Inspection 1065808 for Astrea Fontaine on November 10, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1065808
- Company Name: Astrea Fontaine
- Inspection Date: 2017-11-10
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1300788 - 2024-09-13](https://www.keypedia.com/records/fda_inspections/astrea-fontaine/47705aa4-2072-48dd-9673-8b22abcd626e)
- [FDA Inspection 1300788 - 2024-09-13](https://www.keypedia.com/records/fda_inspections/astrea-fontaine/2ddcc6c5-7412-4b42-b0be-7a71af34dae1)
- [FDA Inspection 1271540 - 2020-12-11](https://www.keypedia.com/records/fda_inspections/astrea-fontaine/14c01510-d958-43bc-ad18-37c263b624bf)
- [FDA Inspection 957802 - 2016-01-22](https://www.keypedia.com/records/fda_inspections/astrea-fontaine/5eaa9da6-0adf-48ca-862c-95eea57f1a6f)

Company: https://www.keypedia.com/companies/astrea-fontaine/1a89a501-6d2f-4c2f-9c7b-e38257d47666

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c